Glaxosmithkline Pharmaceuticals Ltd. Fundamental & Technical Research, Share Price Today

NSE : GLAXO
NIFTY : Nifty 500
NIFTY SECTOR : Nifty MidSmall Healthcare

About Company

Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Market Cap. ₹49,165 Cr.

52 Week - High/Low ₹3,148/1,921

P/E Ratio 57.71

P/B Ratio 27.56

Enterprise Value ₹48,211 Cr.

ROE % 32.96

RSI Value 56.87

EMA 50 2683.22

EMA 200 2479.29

Market Cap. ₹49,165 Cr.

52 Week - High/Low ₹3,148/1,921

P/E Ratio 57.23

P/B Ratio 27.66

Enterprise Value ₹48,210 Cr.

ROE % 33.43

RSI Value 56.87

EMA 50 2683.22

EMA 200 2479.29

Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us